| Dr. Jeffrey Leiden |
Executive Chairman of the Board |
67 |
$8.593M - USD |
Male |
|
| Dr. Reshma Kewalramani |
President, Chief Executive Officer, Director |
50 |
$15.86M - USD |
Female |
|
| Mr. Charles Wagner |
Chief Financial Officer, Executive Vice President |
55 |
$5.812M - USD |
Male |
|
| Mr. Stuart Arbuckle |
Chief Operating Officer, Executive Vice President |
57 |
$15.00M - USD |
Male |
|
| Dr. David Altshuler |
Executive Vice President - Global Research, Chief Scientific Officer |
58 |
$6.525M - USD |
Male |
|
| Dr. Carmen Bozic |
Executive Vice President - Global Medicines Development and Medical Affairs, Chief Medical Officer |
59 |
- |
Female |
|
| Mr. Amit Sachdev |
Executive Vice President, Chief Patient Officer |
55 |
$6.197M - USD |
Male |
|
| Dr. Bastiano Sanna |
Executive Vice President, Chief of Cell and Genetic Therapies |
48 |
- |
Male |
|
| Ms. Ourania Tatsis |
Executive Vice President, Chief Regulatory and Quality Officer |
53 |
$6.584M - USD |
Female |
|
| Ms. Kristen Ambrose |
Senior Vice President, Chief Accounting Officer |
45 |
- |
Female |
|
| Ms. Joy Liu |
Company Secretary |
44 |
- |
Female |
|
| Mr. Bruce Sachs |
Lead Independent Director |
63 |
$600.0K - USD |
Male |
|
| Ms. Nancy Thornberry |
Director |
66 |
- |
Female |
|
| Dr. Sangeeta Bhatia |
Independent Director |
54 |
$550.2K - USD |
Female |
|
| Mr. Lloyd Carney |
Independent Director |
61 |
$552.7K - USD |
Male |
|
| Dr. Alan Garber |
Independent Director |
67 |
$525.0K - USD |
Male |
|
| Mr. Terrence Kearney |
Independent Director |
68 |
$542.7K - USD |
Male |
|
| Mr. Michel Lagarde |
Independent Director |
49 |
- |
Male |
|
| Ms. Diana Mckenzie |
Independent Director |
58 |
$538.2K - USD |
Female |
|
| Mr. Suketu Upadhyay |
Independent Director |
54 |
$469.6K - USD |
Male |
|
